Aetiology and outcome of severe community-acquired pneumonia.
about
Demographics, guidelines, and clinical experience in severe community-acquired pneumoniaBTS Guidelines for the Management of Community Acquired Pneumonia in AdultsStudy of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelinesBiomarkers in community-acquired pneumonia: a state-of-the-art reviewBacteraemic pneumococcal disease in a teaching hospital in Finland.Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort.A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales. British Thoracic Society Research Committee and Public Health Laboratory ServiceCommunity-acquired pneumonia. The changing picture.Effect of oral β-blocker on short and long-term mortality in patients with acute respiratory failure: results from the BASEL-II-ICU studyImpact of management guidelines on the outcome of severe community acquired pneumoniaCommunity-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database.Optimizing treatment outcomes in severe community-acquired pneumonia.Community acquired, nursing home acquired and hospital acquired pneumonia: A five-year review of the clinical, bacteriological and radiological characteristics.Legionnaires' disease: a review of 79 community acquired cases in Nottingham.Grand Rounds--City Hospital, Nottingham. A complicated case of community acquired pneumonia.Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule.Acute pneumonia and systemic lupus erythematosus.Severe community-acquired pneumococcal pneumonia. The French Study Group of Community-Acquired Pneumonia in ICU.Severe community-acquired pneumonia. Assessment of severity criteria.Outcomes of early, late, and no admission to the intensive care unit for patients hospitalized with community-acquired pneumonia.Prognostic factors of severe Legionella pneumonia requiring admission to ICU.Severe community-acquired pneumonia. Epidemiology and prognostic factors.Community acquired lower respiratory tract infection: Refer to the guidelines.Pneumonia: the impact of risk factors on the outcome of treatment with meropenem and ceftazidime.Severe community-acquired pneumonia. Risk factors and follow-up epidemiology.
P2860
Q21195015-3E5E32B4-CD20-4EC0-A5FE-6E012B489E4CQ24675547-CB557D45-67B6-4B2F-8BDC-7FA1F872C45FQ24679117-5E701937-A112-4D3C-9543-0C916F4AFD2AQ27026995-5CDD6660-5882-41CD-9348-0DF0032660C3Q33499098-8F5F787E-CBE3-413F-9960-F9E323007109Q33752549-79701A04-047F-41A9-BD52-A7C9A81562FBQ35533592-3EE03A06-A14F-4D29-9E22-4EA92461FAA7Q35555669-ED104637-A65C-4BDC-B98B-9456D00B3E89Q35561264-B09AC756-A954-4B64-942E-4073B45623E9Q35563097-211868CC-88D8-419B-B521-39E90A0020CDQ35578955-1983297F-0982-4486-8288-8EB17B855813Q35627748-E510BA93-30DA-4FFB-A0FF-71017F05D379Q35893015-2C76FA4F-9615-4473-85B6-629E7AFC4CC8Q36157447-514FDA2A-2018-4DB2-8489-C24B155AAA1BQ36597751-5B6F5CDD-87F4-4DE6-9B25-6D4ECD461A1DQ37210137-16DB4503-2600-4524-ADBE-6B5FDFD1B3BBQ39893324-306CC65C-5683-48E3-9D5D-CC598D8FE737Q40690763-5CF2198A-2A80-43F2-A491-6111C6B73773Q40840154-09630E2E-D3C5-49BA-8351-5B5B0FA6FD95Q43801396-5D3C278C-6AFD-48CA-9B1F-63B73A038469Q44305766-5932B4D4-984A-4BE2-96D3-0CBA65414690Q44626779-C0EF326F-75E2-47C1-893D-DBE4FF9E9DA3Q46207569-1AE1078B-E643-4E29-B4C1-63FF8D71DDF0Q50898088-DD356F24-F9E6-4BAE-82D5-47A8A9C71E55Q54080312-8AD01252-5949-4973-A015-72365FA4221E
P2860
Aetiology and outcome of severe community-acquired pneumonia.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Aetiology and outcome of severe community-acquired pneumonia.
@en
Aetiology and outcome of severe community-acquired pneumonia.
@nl
type
label
Aetiology and outcome of severe community-acquired pneumonia.
@en
Aetiology and outcome of severe community-acquired pneumonia.
@nl
prefLabel
Aetiology and outcome of severe community-acquired pneumonia.
@en
Aetiology and outcome of severe community-acquired pneumonia.
@nl
P2093
P1433
P1476
Aetiology and outcome of severe community-acquired pneumonia.
@en
P2093
A D Macrae
A Laverick
F G Rodgers
J T Macfarlane
M A Woodhead
R Pilkington
P304
P356
10.1016/S0163-4453(85)92463-6
P577
1985-05-01T00:00:00Z